NCT05636514 2026-03-18
CELESTIAL-MDS
Clinical Hub for Interventional Research (CHOIR)
Phase 1 Recruiting
Clinical Trials
8 trialsNCT07120607 2025-08-13
Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia
Anhui Provincial Hospital
Phase 1 Not yet recruiting
NCT06758713 2025-01-06
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
The Third Affiliated Hospital of Southern Medical University
Phase 1 Recruiting
NCT05528887 2022-09-06
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase 1 Recruiting
NCT03881774 2019-03-21
Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies
Henan Cancer Hospital
Phase 1 Unknown
NCT03414450 2018-10-25
Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Phase 1 Withdrawn
NCT01235468 2015-12-03
Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB)
Sheba Medical Center
Phase 1 Withdrawn
NCT00636922 2013-02-15
Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia
Bayside Health
Phase 1 Unknown